Getty Images
A woman died in Virginia after receiving Johnson & Johnson’s COVID vaccine: another woman is in critical condition
This alarm went off in the United States on Tuesday after the CDC (Centers for Disease Control and Prevention) and the FDA (Food and Drug Administration of the United States) revealed that of the nearly 7 million doses from Johnson & Johnson’s COVID vaccine, 6 people reported having a worrisome side effect: blood clots. For this reason, they requested that the use of this drug be temporarily discontinued until they had fully investigated the cases.
Most troubling of all, of the six people who experienced serious side effects after receiving the dose of J&J, one of them, a Virginia state woman, died.
Another, from the state of Nebraska, is in a critical condition in a hospital, as revealed by the New York Times.
The aforementioned media added that both the deceased woman who received the Johnson & Johnson vaccine and the one who was hospitalized, as well as the other four remaining, were all female patients, aged between 18 and 48 years.
FOX News revealed that health authorities are investigating the death of the woman whose identity has not been disclosed within the broader investigation they began to learn about the “adverse side effects” of the Johnson & Johnson vaccine.
FOX quoted Virginia vaccination coordinator Danny Avula as confirming that the death of the woman in question occurred last March and is under investigation to determine whether or not there were any effects related to the Johnson & Johnson vaccine that could have been performance. .
The official warned that when the woman died, she was reported to the CDC’s Vaccine Adverse Event Notification System.
“We are closely following the federal government’s actions to stop all Johnson & Johnson vaccines while investigating an extremely rare potential side effect. In Virginia, we will be discontinuing all Johnson & Johnson vaccines until this investigation is completed, ”the official said in his statement.
“This pause is reassuring as it shows that the systems that exist to monitor vaccine safety are working. We expect a thorough review by federal health officials. In the meantime, at this point, we will continue to launch the Virginia vaccine with the other two approved vaccines developed by Pfizer and Moderna, ”he added. “People who have received the Johnson & Johnson vaccine who develop a severe headache, abdominal pain, leg pain, or shortness of breath within three weeks of vaccination should contact their healthcare provider or call the emergency number if it is a medical emergency.”
As for the woman in serious condition in the state of Nebraska, local television news 6 News assured that she is a 48-year-old woman “vaccinated with Johnson & Johnson Lot No. 1805020 on March 9”.
Regarding her condition, the aforementioned media said: “She is currently hospitalized with deep bleeding and coagulation, suspected dysfibrinogenemia…. The CDC report, through the Vaccine Adverse Event Reporting System, known as VAERS, lists the woman’s condition as serious and “life-threatening.”
After disclosing the situation with the Johnson & Johnson vaccine, Dr. Peter Marks, director of the FDA’s Center for Biological Research and Evaluation, and Dr. Anne Schuchat, CDC Senior Deputy Director, in a statement:
“People who have received the J&J vaccine and develop a severe headache, abdominal pain, leg pain, or shortness of breath within three weeks of vaccination should contact their healthcare provider.”
“Healthcare providers are asked to report adverse reactions to the Vaccine Adverse Event Reporting System at https://vaers.hhs.gov/reportevent.html,” she added.
Officials added, “At the moment, these adverse events appear to be extremely rare. The safety of the COVID-19 vaccine is a top priority for the federal government, and we take all reports of health problems following vaccination with COVID-19 very seriously. “
FDA and @RTLNews released a statement on the Johnson & Johnson vaccine before #COVID-19We recommend taking a break when using this vaccine as a precaution. https://t.co/EOaNEScaRL
– US FDA in Spanish (@FDAenEspanol) April 13, 2021
Regarding the findings in the six reported cases, they said: “In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was observed in conjunction with a low platelet count in the blood (thrombocytopenia). All six cases occurred in women between the ages of 18 and 48 and symptoms appeared 6 to 13 days after vaccination. The treatment for this specific type of blood clot is different from the treatment normally given. Usually a blood thinning medication called heparin is used to treat blood clots. In this context, the administration of heparin can be dangerous and it is necessary to administer alternative treatments ”.
Follow Now Same on Instagram
